ReviewJapanese journal of radiology2026
Imaging-detected extranodal extension in head and neck cancer: clinical implications, diagnostic criteria, and the potential of photon-counting detector CT.
Review in Japanese journal of radiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Article
- Photon-counting CT in head and neck radiology: bridging detector physics and clinical applications.European radiology · 2026Review
- Article
- Imaging-Detected Extranodal Extension in Head and Neck Cancer: Clinical Significance and a Standardized Imaging Assessment.Journal of the Korean Society of Radiology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
Imaging-detected extranodal extension (iENE) is increasingly recognized as an objective adverse prognostic factor in head and neck cancer. The newly published 9th edition of the UICC/AJCC TNM Classification now incorporates iENE into the nodal (N) categories for nasopharyngeal carcinoma, HPV-associated oropharyngeal carcinoma, and salivary gland carcinoma, typically upstaging patients to higher N categories, and designates imaging findings as an accepted standard for the clinical ENE (cENE) as the N3b category in all other head and neck subsites. To establish diagnostic criteria for iENE, the Head and Neck Cancer International Group (HNCIG) has proposed a four-tier grading system (2024): Grade 0 (iENE-negative), Grade 1 (perinodal fat extension), Grade 2 (coalescent lymph nodes), and Grade 3 (invasion of adjacent structures). Each grade carries distinct clinical implications, ranging from treatment de-escalation for Grade 0 to consideration of unresectable disease for Grade 3. Recent advances in ultra-high-resolution imaging, particularly photon-counting detector CT (PCD-CT) with 1024 × 1024 matrix in super-high-resolution (SHR) mode, may offer the spatial details necessary to more reliably detect these subtle findings compared with conventional imaging. Through direct comparisons with histopathological correlations, we demonstrate the potential of high-resolution imaging in detecting iENE. PCD-CT, with its simultaneous spectral imaging capabilities-including virtual monochromatic imaging-enhances soft tissue contrast for detecting subtle ENEs. In addition, material decomposition maps aid in the precise evaluation of tumor-tissue interfaces. This comprehensive review is an educational resource for radiologists applying the HNCIG consensus criteria including the newly adopted TNM staging requirements. While advanced imaging technologies such as PCD-CT show promising potential for enhanced tissue characterization, further validation studies are needed to establish their clinical utility in routine iENE assessment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.